3,028
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry

, , , , , & ORCID Icon show all
Pages 5996-6009 | Received 04 Jun 2021, Accepted 20 Aug 2021, Published online: 08 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Renhou Zhi, Pengfei Hao, Weibin Li & Haoliang Zhao. (2023) Expression of CKS2 in Hepatocellular Carcinoma: Correlation with Survival Outcomes and Immune Microenvironment. Journal of Hepatocellular Carcinoma 10, pages 1767-1784.
Read now
Wenjun Jiang, Xiaoying Wang, Siwei Su, Sen Du & Hongqiang Song. (2022) Identifying the shared genes and KEGG pathways of Resolvin D1-targeted network and osteoarthritis using bioinformatics. Bioengineered 13:4, pages 9839-9854.
Read now

Articles from other publishers (3)

Ziteng Li, Yuanzhen ChenBo ZhangLiangyu XieBin Shi. (2023) Global trends and hotspots in Cyclin-dependent Kinase Subunit 2 research from 1999 to 2022: A bibliometric and visualized analysis. Medicine 102:48, pages e36319.
Crossref
Wenqian Zhi, Ye Wang, Chenyu Jiang, Yuqin Gong, Qiuyan Chen, Xiang Mao, Wensheng Deng & Shasha Zhao. (2023) PLEKHA4 is a novel prognostic biomarker that reshapes the tumor microenvironment in lower-grade glioma. Frontiers in Immunology 14.
Crossref
Yu Miao, Dongqiang SuQian Fu, Taoyu Chen, Yanqi Ji & Feng Zhang. (2022) Identification of CKS2 and RRM2 as potential markers of vitiligo using bioinformatics analysis. Medicine 101:46, pages e31908.
Crossref